Atul Deodhar

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Michael M. Ward, Atul Deodhar, Lianne S. Gensler et al. · Arthritis & Rheumatology · 2019 · 631 citations

Medicine, Internal Medicine, Pharmacotherapy +16

American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Michael M. Ward, Atul Deodhar, Elie A. Akl et al. · Arthritis & Rheumatology · 2015 · 549 citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +17

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie et al. · Arthritis & Rheumatology · 2018 · 481 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Robert Landewé, Jürgen Braun, Atul Deodhar et al. · Annals of the Rheumatic Diseases · 2013 · 468 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11